Imaginostics

Imaginostics

Innovative Diagnostic Solutions

Founded 2018

Cambridge, United States 8 employees Grant Total: $3.13M Biotechnology, Health Care

Imaginostics is a biotechnology startup based in the United States, founded in 2018. The company's slogan, "Innovative Diagnostic Solutions," aptly captures its mission. Imaginostics is dedicated to creating the next generation of precision medicine diagnostic tools, aiming to serve clinicians and drug developers to transform personalized healthcare, accelerate drug development, and combat aging. The company's proprietary MRI physics-based technology sets it apart, offering a significant advancement in diagnostic imaging. This technology promises 10X better vascular images and quantitative measurements for vascular structure, function, and leakage. Notably, the technology and software are compatible with existing MRI scanners, providing added convenience. Moreover, it is compatible with safe iron supplements for contrast, eliminating the need for gadolinium. Imaginostics' focus on providing biomarker solutions through Contract Research Organizations (CROs) to pharma, coupled with its involvement in pre-clinical and clinical research, positions the company as a key player in the healthcare and biotechnology sectors. Its collaborations with world-renowned researchers at leading institutions underscore the company's commitment to advancing medical diagnostics and research. The startup recently received a $915.93K grant investment on 15 September 2022 from the National Institute on Aging, further validating its potential and attractiveness to investors. For more information, visit www.imaginostics.com.

Funding Stage	Amount	Investors	Lead Investors	Date
Grant	$915.93K	1	National Institute on Aging	15 Sep 2022
Seed Round	$725.00K	1	Alzheimer's Drug Discovery Foundation	06 Sep 2022
Seed Round	$50.00K	1	UB Ventures	01 May 2022
Grant	$436.56K	1	National Institute of Mental Health	22 Jan 2022
Seed Round	$600.00K	1	Ideaship	01 Jan 2021
Seed Round	$400.00K	-		01 Jul 2018

Funding Stage

Amount

Investors

Lead Investors

Date

Grant

$915.93K

National Institute on Aging

15 Sep 2022

Seed Round

$725.00K

Alzheimer's Drug Discovery Foundation

06 Sep 2022

Seed Round

$50.00K

UB Ventures

01 May 2022

Grant

$436.56K

National Institute of Mental Health

22 Jan 2022

Seed Round

$600.00K

Ideaship

01 Jan 2021

Seed Round

$400.00K

01 Jul 2018

FAQ About Imaginostics

Innovative Diagnostic Solutions

Imaginostics was founded in 2018.

Imaginostics is headquartered in Cambridge, United States.

Imaginostics operates in Biotechnology and Health Care. Its work centres on Precision Medicine, Diagnostic Tools, MRI Technology and Vascular Imaging.

Imaginostics has approximately 8 employees.

Imaginostics has completed 6 funding rounds, raising a total of $3.13M. The latest funding stage is Grant.

Top alternatives and competitors to Imaginostics include SynchroPET, Polaris Biology, Magnetic Insight, Inc, SuperSonic Imagine, ViewRay, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Imaginostics and SynchroPET are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About Imaginostics

Funding Rounds & Investors (6)

Imaginostics Alternatives & Competitors

FAQ About Imaginostics